These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 8433391

  • 1. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC.
    J Natl Cancer Inst; 1993 Mar 03; 85(5):377-84. PubMed ID: 8433391
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H.
    Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906
    [Abstract] [Full Text] [Related]

  • 3. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 4. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
    Svensson T, Rydén M, Schilling FH, Dominici C, Sehgal R, Ibáñez CF, Kogner P.
    Eur J Cancer; 1997 Oct 25; 33(12):2058-63. PubMed ID: 9580079
    [Abstract] [Full Text] [Related]

  • 5. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
    Tanaka T, Hiyama E, Sugimoto T, Sawada T, Tanabe M, Ida N.
    Cancer; 1995 Sep 15; 76(6):1086-95. PubMed ID: 8625212
    [Abstract] [Full Text] [Related]

  • 6. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC.
    J Natl Cancer Inst; 1995 Oct 04; 87(19):1470-6. PubMed ID: 7674334
    [Abstract] [Full Text] [Related]

  • 7. Expression and function of TRK-B and BDNF in human neuroblastomas.
    Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM.
    Mol Cell Biol; 1994 Jan 04; 14(1):759-67. PubMed ID: 8264643
    [Abstract] [Full Text] [Related]

  • 8. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
    Nakagawara A, Kadomatsu K, Sato S, Kohno K, Takano H, Akazawa K, Nose Y, Kuwano M.
    Cancer Res; 1990 May 15; 50(10):3043-7. PubMed ID: 2185879
    [Abstract] [Full Text] [Related]

  • 9. High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.
    Miyake M, Suzuki T, Shimada H, Stram D, Seeger RC.
    Prog Clin Biol Res; 1994 May 15; 385():163-8. PubMed ID: 7972208
    [No Abstract] [Full Text] [Related]

  • 10. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
    Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G.
    Prog Clin Biol Res; 1994 May 15; 385():137-45. PubMed ID: 7972205
    [Abstract] [Full Text] [Related]

  • 11. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
    Rydén M, Sehgal R, Dominici C, Schilling FH, Ibáñez CF, Kogner P.
    Br J Cancer; 1996 Sep 15; 74(5):773-9. PubMed ID: 8795581
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
    Matsunaga T, Shirasawa H, Tanabe M, Ohnuma N, Kawamura K, Etoh T, Takahashi H, Simizu B.
    Int J Cancer; 1994 Sep 15; 58(6):793-8. PubMed ID: 7523310
    [Abstract] [Full Text] [Related]

  • 15. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo.
    Matsushima H, Bogenmann E.
    Mol Cell Biol; 1993 Dec 15; 13(12):7447-56. PubMed ID: 8246962
    [Abstract] [Full Text] [Related]

  • 16. Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
    Combaret V, Gross N, Lasset C, Balmas K, Bouvier R, Frappaz D, Beretta-Brognara C, Philip T, Favrot MC, Coll JL.
    Br J Cancer; 1997 Dec 15; 75(8):1151-5. PubMed ID: 9099963
    [Abstract] [Full Text] [Related]

  • 17. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
    de Souza DR, Sanabani SS, de Souza AC, Filho Odone V, Epelman S, Bendit I.
    Pediatr Blood Cancer; 2011 May 15; 56(5):749-56. PubMed ID: 21154590
    [Abstract] [Full Text] [Related]

  • 18. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening.
    Tanaka T, Sugimoto T, Sawada T.
    Cancer; 1998 Oct 15; 83(8):1626-33. PubMed ID: 9781958
    [Abstract] [Full Text] [Related]

  • 19. Expression of TrkA, TrkB and TrkC in human neuroblastomas.
    Brodeur GM, Nakagawara A, Yamashiro DJ, Ikegaki N, Liu XG, Azar CG, Lee CP, Evans AE.
    J Neurooncol; 1997 Jan 15; 31(1-2):49-55. PubMed ID: 9049830
    [Abstract] [Full Text] [Related]

  • 20. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y, Hemmi H, Inoue A, Obana K, Yang HW, Hayashi Y, Kanda N, Shimatake H.
    Tumour Biol; 1996 Jan 15; 17(2):65-74. PubMed ID: 8658015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.